z-logo
open-access-imgOpen Access
Distribution of sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients and environment in Iran
Author(s) -
Adabi Maryam,
Jabbari Mosadegh,
Rastegar Lari Abdolaziz
Publication year - 2011
Publication title -
african journal of microbiology research
Language(s) - English
Resource type - Journals
ISSN - 1996-0808
DOI - 10.5897/ajmr11.154
Subject(s) - vibrio cholerae , microbiology and biotechnology , sulfamethoxazole , trimethoprim , antibiotics , streptomycin , chloramphenicol , biology , bacteria , genetics
The occurrence of drug-resistant Vibrio cholerae is being reported with increasing frequency worldwide. Spread of resistant strains has been attributed, in part, sulfamethoxazole trimethoprimconstin (SXT-C). Sixty V. cholerae isolates obtained from cholera patients from different provinces in Iran during 2004 to 2006 and thirty-seven V. cholerae strains from surface water sources at 5 different locations in Tehran, Iran during 2006 were subjected to antibiotic susceptibility testing and polymerase chain reaction amplification of SXT-C. In clinical isolates the highest and the least levels of antibiotic resistance were seen to SXT, streptomycin and chloramphenicol (95, 95 and 92%, respectively) and doxycycline, gentamicin and oxytetracycline (0, 3 and 3%, respectively). PCR for SXT element of clinical and environmental isolates was positive for 95 and 19% of isolates, respectively. The results of this study showed that among the clinical and environmental V. cholerae resistance to SXT, streptomycin and chloramphenicol could be, in part, due to wide distribution of SXT-C isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom